Health
SK Bioscience embarks on clinical test of COVID-19 vaccine candidate NBP2001 – Aju Business Daily
[Courtesy of SK Bioscience]SEOUL — SK Bioscience, a cooperation partner for South Koreas state project to develop COVID-19 vaccines, will immediately embark on…
[Courtesy of SK Bioscience]
SEOUL — SK Bioscience, a cooperation partner for South Korea’s state project to develop COVID-19 vaccines, will immediately embark on the first phase of clinical trials to evaluate the safety and immunogenicity of its vaccine candidate called NBP2001. The first test will be conducted on healthy adults at a state-run hospital.The Ministry of Food and Drug Safety said that SK Bioscience has been allowed to carry out clinical trials of NBP2001, a recombinant vaccine manufactured…
-
Business23 hours agoWhat I’d buy if I had to invest $20,000 in ASX 200 shares before the weekend
-
General22 hours agoFederal government funding extends cohealth GP services until July 2026
-
General6 hours agoMildura man given 28 years to pay $73,000 in unpaid fines and tolls
-
General9 hours agoAustralia’s race to rewire the country amid a global transmission boom is not unique